Evidence map›Paper›PMID 35766707›Full record

ArticleBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica2022

Using data from a private provider of telemedicine to assess the severity of the early 2021 Covid-19 wave in Brazil.

P M Barbosa, F C da Silva Júnior, G M C Lima, S Bertini, R R de Lima, K A Furuta, C H Mapa, L Roschel, E Oliveira

Abstract read
In one paragraph

Article in Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

P M BarbosaSaude iD, Grupo Fleury, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0001-7220-1563
F C da Silva JúniorSaude iD, Grupo Fleury, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0001-9482-5246
G M C LimaSaude iD, Grupo Fleury, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-6456-2761
S BertiniSaude iD, Grupo Fleury, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0003-0719-9270
R R de LimaSaude iD, Grupo Fleury, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-5505-0895
K A FurutaSaude iD, Grupo Fleury, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0003-3135-4111
C H MapaSaude iD, Grupo Fleury, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-6322-2255
L RoschelSaude iD, Grupo Fleury, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0001-9597-3558
E OliveiraSaude iD, Grupo Fleury, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-4352-2285

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In early 2021, Brazil saw a dramatic recurrence in Covid-19 cases associated to the spread of a novel variant of the SARS-CoV-2 virus, the P1 variant. In light of previous reports showing that this variant is more transmissible and more likely to infect people who had recovered from previous infection, a retrospective analysis was conducted to assess if the early 2021 Covid-19 wave in Brazil was associated with an increase in the number of individuals presenting with a more severe clinical course. Fifty-one thousand and fourteen individuals who underwent telemedicine consultations were divided into two groups: patients seen on or before January 31, 2021, and on or after February 1, 2021. These dates were chosen based on the spread of the P1 variant in Brazil. Referral to the emergency department (ED) was used as a marker of a more severe course of the disease. No differences were seen in the proportion of patients referred to the ED in each group nor in the odds ratio of being referred to the ED from the 1st of February 2021 (OR=0.909; 95%CI: 0.81-1.01). Considering the entire cohort, age had an impact on the odds of being referred to the ED, with individuals older than 59 years showing twice the risk of the remaining population and those less than 19 years showing a lower risk.

Indexed as

COVID-19TelemedicineBrazilHumansMiddle AgedRetrospective StudiesSARS-CoV-2

Identifiers

PMID35766707
PMCPMC9224816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.